Follow this organization
[ via
] [?]
Children's Hospital Boston
The mission of the Technology and Innovation Development Office (TIDO) is to translate the laboratory and clinical research excellence of Children’s Hospital Boston into products for the public benefit. TIDO uses a multi-faceted approach to promote, support and develop research, technology and clinical innovations through the protection and licensing of intellectual property, investing in Children’s Hospital technologies, and establishing strong research and development partnerships with industry throughout the innovation to product life cycle.
Innovations (153):
- Novel Biological Treatment Paradigm for Heart Failure (15 JUL 10)
- Modulators of Nitric Oxide Signaling for the Stimulation Hematopoietic Stem Cells (02 JUL 10)
- Treatment and Diagnostic for Melanomas (02 JUL 10)
- Novel Two Piece Replacement Heart Valve Delivered via Transcatheter (27 JUN 10)
- Catheter-based septal defect closure device (27 JUN 10)
- Novel peptides to promote wound healing and neuroprotection (30 APR 10)
- Defining physiological functions of syndecan-1 in health and disease using the syndecan-1 null mice (19 MAR 10)
- Novel drugs targeting metastatic cancers (17 FEB 10)
- Frame rate enhancement of three dimensional echo cartographic sequences of beating hearts (12 FEB 10)
- Bipolar coagulator for revision of CSF shunts (05 FEB 10)
Communities (0):
Children's Hospital Boston isn't a member of any communities.
|
|
Institute Administrator Innovations (0) |
|---|
ProfileFind more innovations
